| Megan Desai, MD | |
|
4220 Harding Pike, Nashville, TN 37205-2005 | |
| (615) 222-6726 | |
| (615) 222-3702 |
| Full Name | Megan Desai |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 10 Years |
| Location | 4220 Harding Pike, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003234071 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Saint Thomas Highlands Hospital | Sparta, TN | Hospital |
| Saint Thomas River Park Hospital | Mc minnville, TN | Hospital |
| Dekalb Community Hospital | Smithville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acla Pc | 9133117534 | 14 |
News Archive
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
The Court said the benefits are protected under the Illinois Constitution. The state wants to cut the benefits to save money on the state's pension liabilities.
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Harris Corporation, an international communications and information technology company, has been selected by the Department of Veterans Affairs to participate in the Mentor-Protege Program with 7 Delta, Inc., a Service-Disabled Veteran-Owned Small Business.
IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.
› Verified 5 days ago
| Entity Name | Acla Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891995163 PECOS PAC ID: 9133117534 Enrollment ID: O20040504001214 |
News Archive
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
The Court said the benefits are protected under the Illinois Constitution. The state wants to cut the benefits to save money on the state's pension liabilities.
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Harris Corporation, an international communications and information technology company, has been selected by the Department of Veterans Affairs to participate in the Mentor-Protege Program with 7 Delta, Inc., a Service-Disabled Veteran-Owned Small Business.
IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Desai, MD 2004 Hayes St # Ll30, Nashville, TN 37203-2646 Ph: (615) 284-7950 | Megan Desai, MD 4220 Harding Pike, Nashville, TN 37205-2005 Ph: (615) 222-6726 |
News Archive
nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study sites across the United States.
The Court said the benefits are protected under the Illinois Constitution. The state wants to cut the benefits to save money on the state's pension liabilities.
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Harris Corporation, an international communications and information technology company, has been selected by the Department of Veterans Affairs to participate in the Mentor-Protege Program with 7 Delta, Inc., a Service-Disabled Veteran-Owned Small Business.
IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.
› Verified 5 days ago
Dr. Digna Saunders Forbes, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1005 Dr. D. B. Todd Blvd, Nashville, TN 37208 Phone: 615-327-6438 Fax: 615-327-5634 | |
Mary Ann Arildsen, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Eszter Szentirmai, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Henry Douglas Edwards, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2010 Church St, Ste 615, Nashville, TN 37203 Phone: 615-284-7950 Fax: 615-284-5750 | |
Dr. Robert Eugene Burnette, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1005 Dr. D. B. Todd Blvd, Nashville, TN 37208 Phone: 615-327-6212 Fax: 615-327-6409 | |
James Chappell, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Andy Lo, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2601 Tvc, Nashville, TN 37232 Phone: 615-322-4916 |